Bromocriptine Capsules and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Bromocriptine Capsules and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bromocriptine
Brand name: Parlodel, Cycloset
Synonyms: Bromocriptine
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bromocriptine Capsules-Pneumococcal 13-valent conjugate vaccine
- Bromocriptine Capsules-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Bromocriptine Capsules-Pneumococcal Conjugate Vaccine (13-Valent)
- Bromocriptine Capsules-Pneumococcal Conjugate Vaccine (7-Valent)
- Bromocriptine Capsules-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Bromocriptine Capsules-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-Bromocriptine Mesylate
- Pms-Sodium Polystyrene Sulfonate-Brompheniramine
- Pms-Sodium Polystyrene Sulfonate-Brompheniramine and codeine
- Pms-Sodium Polystyrene Sulfonate-Brompheniramine and phenylephrine
- Pms-Sodium Polystyrene Sulfonate-Brompheniramine and Phenylephrine Chewable Tablets
- Pms-Sodium Polystyrene Sulfonate-Brompheniramine and Phenylephrine Liquid